alexa Abstract | Cost-minimization Analysis between Sevelamer and Lanthanum in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China

Journal of Health & Medical Economics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

Background: Hyperphosphatemia is a great challenge for all countries, which contributes to vascular calcification and is associated with all-cause mortality for patients with chronic kidney disease. There are evidences showing the better efficacy in mortality, hospitalization of non-calcium based phosphate binders versus calcium-based phosphate binders. This study aims to provide scientific evidence on economic evaluation between two new non-calcium based phosphate binders, sevelamer and lanthanum, among end-stage renal disease patients in China through cost-minimization analysis from a patient perspective. Methods: A cost-minimization analysis comparing sevelamer and lanthanum was conducted based on a review of current clinical evidence in treating hyperphosphatemia in China. The local unit costs, the equivalent dose ratios, estimated daily doses and survival extrapolation in published studies were applied. Results: Our cost analysis indicates that sevelamer is likely to cost less than lanthanum in the local  ontext of China with potential savings of up to approximately RMB 38,000 per patient over an estimated survival projection of 5.38 years for a dialysis patient with hyperphosphatemia. Conclusion: For the treatment of hyperphosphatemia in end-stage renal disease patients in China, our analysis demonstrates sevelamer being likely a cost-saving option compared to lanthanum, both non-calcium based phosphate binders that provide more efficacious alternatives than calcium-based phosphate binders. 

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Li Yang Seng Chuen Tan Can Chen and Xinya Li

Keywords

Hyperphosphatemia, Disease burden, Phosphate binder, Sevelamer, Cost-minimization, China, Behavioral Economics, Burden of Disease, Cost Benefits, Demand and Supply, Disease Management, Health Consumerism, Health Crisis, Health Economics, Health insurance, Medical Debt, Pharmacoeconomics, Prescription Costs, Pharmacoepidemiology, Outcomes and Clinical Trials Data, Cost Minimization, Modelling Studies, Pharmaceutical Products, Financial Information

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version